Drug
Beclometasone Formoterol Glycopyrrolate
Beclometasone Formoterol Glycopyrrolate: highest development phase Phase 3, developed by Chiesi Farmaceutici. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chiesi Farmaceutici
Trials
| Drug | Phase | Indication |
|---|---|---|
| Beclometasone/Formoterol/Glycopyrrolate NCT01917331 | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) |
Latest
No recent events.
Follow Beclometasone Formoterol Glycopyrrolate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.